Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Moleculin Biotech (MBRX) Debt Ratio (2017 - 2022)

Moleculin Biotech (MBRX) has 6 years of Debt Ratio data on record, last reported at 0.0 in Q4 2022.

  • For Q4 2022, Debt Ratio rose 15.54% year-over-year to 0.0; the TTM value through Dec 2022 reached 0.0, up 15.54%, while the annual FY2022 figure was 0.0, 15.54% up from the prior year.
  • Debt Ratio reached 0.0 in Q4 2022 per MBRX's latest filing, down from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.22 in Q3 2019 and bottomed at 0.0 in Q1 2021.
  • Average Debt Ratio over 5 years is 0.04, with a median of 0.0 recorded in 2019.
  • Peak YoY movement for Debt Ratio: soared 1170.69% in 2019, then plummeted 98.37% in 2020.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2018, then tumbled by 57.31% to 0.0 in 2019, then crashed by 31.51% to 0.0 in 2020, then plummeted by 51.76% to 0.0 in 2021, then grew by 15.54% to 0.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.0 in Q4 2022, 0.0 in Q3 2022, and 0.0 in Q2 2022.